Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Asset Utilization Ratio (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.69 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 19.43% to 0.69 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.69, a 19.43% decrease, with the full-year FY2024 number at 0.87, down 22.44% from a year prior.
  • Asset Utilization Ratio was 0.69 for Q3 2025 at Gyre Therapeutics, down from 0.72 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 16.8 in Q3 2023 to a low of 0.05 in Q2 2021.
  • A 5-year average of 2.06 and a median of 0.79 in 2025 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: soared 29964.01% in 2023, then plummeted 94.92% in 2024.
  • Gyre Therapeutics' Asset Utilization Ratio stood at 0.11 in 2021, then soared by 1524.26% to 1.77 in 2022, then grew by 1.5% to 1.79 in 2023, then tumbled by 52.95% to 0.84 in 2024, then decreased by 18.53% to 0.69 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Asset Utilization Ratio are 0.69 (Q3 2025), 0.72 (Q2 2025), and 0.79 (Q1 2025).